Hanneke WM van Laarhoven

Author

University of Amsterdam

Also Known As

H WM van Laarhoven, Hanneke W.M. van Laarhoven, Hanneke WM Van Laarhoven, Hanneke WM van Laarhoven

Publications

806

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Radboud University Nijmegen Amsterdam UMC Location University of Amsterdam Amsterdam University Medical Centers Radboud University Medical Center

About

Hanneke WM van Laarhoven is an author at University of Amsterdam specializing in cancer research, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	338
2	Health Sciences	1	1	320
3	Nursing	1	1	18
4	Family Medicine	1	1	18
5	Gastroenterology	1	1	320

Hanneke WM van Laarhoven

Publications

744

Citations

H-Index

Page 1

	Year	Citations
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study Bo Jan Noordman, Manon C.W. Spaander, Roelf Valkema, The Lancet Oncology Residual DiseaseSurgical OncologyEsophageal CancerGastrointestinal OncologyMedicine	2018	320
Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response Marloes Wennemers, Johan Bussink, Blanca Scheijen, Breast Cancer Research	2011	87
Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with <i>IDH1</i> -mutated or <i>IDH2</i> -mutated solid tumours Remco J. Molenaar, Robert J.S. Coelen, Mohammed Khurshed, BMJ Open	2017	79
Shared decision making about palliative chemotherapy: A qualitative observation of talk about patients’ preferences Inge Henselmans, Hanneke WM van Laarhoven, Jane Van der Vloodt, Palliative Medicine	2016	68
High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1 Anne Steins, Madelaine G. van Mackelenbergh, Amber P. van der Zalm, EMBO Reports	2020	39
Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma Nadia Haj Mohammad, Maarten C.C.M. Hulshof, Jacques Bergman, BMC Cancer	2014	28
The life in sight application study (LISA): design of a randomized controlled trial to assess the role of an assisted structured reflection on life events and ultimate life goals to improve quality of life of cancer patients Renske Kruizinga, Michael Scherer‐Rath, Johannes BAM Schilderman, BMC Cancer	2013	24
Tumor‐immune landscape patterns before and after chemoradiation in resectable esophageal adenocarcinomas Tanya T.D. Soeratram, Aafke Creemers, Sybren L. Meijer, The Journal of Pathology	2021	23
Trends in treatment and overall survival among patients with proximal esophageal cancer Judith de Vos‐Geelen, Sandra M. E. Geurts, Margreet van Putten, World Journal of Gastroenterology	2019	19
An assisted structured reflection on life events and life goals in advanced cancer patients: Outcomes of a randomized controlled trial (Life InSight Application (LISA) study) Renske Kruizinga, Michael Scherer‐Rath, Johannes BAM Schilderman, Palliative Medicine NursingFamily MedicineQuality Of LifePalliative CareControl Group	2018	18

Page 1